Member State to which the notification was sent
Date of acknowledgement from the Member State Competent Authority
Title of the Project
Field trials with insect resistance and glufosinate ammonium herbicide tolerant cotton transformation event GHB119 for:
• Biodiversity studies on insect population and soil microflora population.
• Dissemination studies on gene flow to other cultivated cotton.
• Agronomic evaluation (basic agronomic performance, survivability and dormancy).
• Production of material for:
-nutritional and toxicological evaluation;
Proposed period of release:
21/03/2006 to 20/03/2009
Name of the Institute(s) or Company(ies)
Bayer BioScience N.V., Technologiepark 38
3. Is the same GMPt release planned elsewhere in the Community?
Has the same GMPt been notified elsewhere by the same notifier?
If yes, notification number(s):
USA: (APHIS: 02-288-03n, 03-064-15n, 03-254-01n, 04-064-11n, 05-035-10n, 05-035-12n, 05-257-05n, 05-257-06n)
USA: (EPA: 264-EUP-RUR)
Genetically modified plant
Complete name of the recipient or parental plant(s)
`Coker312, other breeding
2. Description of the traits and characteristics which have been introduced or modified, including marker genes and previous modifications:
Insect resistant and glufosinate ammonium herbicide tolerance.
3. Type of genetic modification:
In case of insertion of genetic material, give the source and intended function of each constituent fragment of the region to be inserted:
Genetic elements which confer the phenotype insect resistant and glufosinate ammonium herbicide tolerance:
-cry2: Coding sequence of cry gene from Bacillus thuringiensis that confers the insect resistance trait.
- bar : Coding sequence of the phosphinothricin acetyltransferase gene (bar) from Streptomyces hygroscopicus that confers the herbicide resistance trait.
Refer to the Confidential Annex for further information.
6. Brief description of the method used for the genetic modification:
The transgenic cotton lines are generated using disarmed Agrobacterium-mediated transformation.
7. If the recipient or parental plant is a forest tree species, describe ways and extent of dissemination and specific factors affecting dissemination:
1. Purpose of the release:
The purpose of this study is to evaluate agronomic, nutritional and toxicological aspects of the transformation event and to produce reference material. It will be studied also the environmental behavior (survivability, dormancy) of the Genetically Modified Organism under the climatic conditions of the Spanish cotton cultivation zone. No crosses are planned.
2. Geographical location of the site:
Province of Tarragona: Mont Roig, Uldecona, Vinyols, L’Aldea.
Province of Lerida: Albesa, Torres de Segre, Belloc.
3. Size of the site (m2):
Field trials for agronomic, toxicological and nutritional evaluation with the transformation event will be included in field trials with other transformation events. The transformation event GHB119 will cover a total surface of 180m2, in the field trial localization that will be of 2 ha. An additional plot of 144 m2 will be present in 2 of the 8 localizations for the gene flow studies.
The field trial for the reference material production will cover a surface of 2500 m2.
4. Relevant data regarding previous releases carried out with the same GM-plant, if any, specifically related to the potential environmental and human health impacts from the release:
The previous releases took place in the continental US or in Puerto Rico, from 2001 through 2005. A summary of observations to date include:
- The genetic change appears stable
- The new insect resistant and glufosinate ammonium tolerant cotton varieties share the characteristics of cotton plants in agricultural production
- There is no cause for concern to non-target organisms presented by the new plant varieties
- The potential for gene flow, the transfer of insect resistance or glufosinate ammonium herbicide tolerance to conventional or wild cotton relatives, is low.
- The consequence of gene flow would not be detrimental to current agronomic systems and can be managed by current agricultural practices.
Environmental Impact and Risk Management
Summary of the potential environmental impact from the release of the GMPts:
Genetically modified cotton has the same behavior as conventional cotton except for the characters encoded by the inserted genes.
Due to the measures taken in the trials and the lack of wild relatives of cotton in Europe, BCS consider that gene transfer is unlikely to happen, neither to other species nor to conventional cotton.
However if a weed or a volunteer would receive the transgene, this would not confer any selective advantage in the absence of glufosinate treatment.
This transgenic cotton has been tested at various locations in the US and in Costa Rica and post-harvest monitoring did not report any adverse effects on the environment.
Brief description of any measures taken for the management of risks:
The trials will be conducted with an isolation distance of 200 m from any other cotton. The field trial sites will be surrounded with at least 4 rows of non-transgenic cotton (pollen trap) which will be destroyed after flowering. The multiplication assay will be isolated by 1.5 km from any other cotton field.
The products harvested from the field trials will be used for experimental purposes or destroyed.
Each site will be visited on a regular basis during the trial period.
Summary of foreseen field trial studies focused to gain new data on environmental and human health impact from the release:
The planned field trials are designed in order to:
1- Evaluate agronomic, toxicological and nutritional aspects
2- Evaluate the environmental behavior (survivability, dormancy) of the Genetically Modified Organism under the climatic conditions of the Spanish cotton cultivation zone
3-To produce reference material
The planned field trials are not designed to address the impact of the release on human health.
European Commission administrative information
Consent given by the Member State Competent Authority:
The competent authority for give the consent of these field trials is the Autonomous Community of Cataluña.